Results 241 to 244 of about 3,798,723 (244)

Osimertinib Western and Asian clinical pharmacokinetics in patients and healthy volunteers: implications for formulation, dose, and dosing frequency in pivotal clinical studies

Cancer Chemotherapy and Pharmacology, 2016
D. Planchard, K. Brown, Dong-Wan Kim, Sang-We Kim, Y. Ohe, E. Felip, P. Leese, M. Cantarini, K. Vishwanathan, P. Jänne, M. Ranson, P. Dickinson   +11 more
semanticscholar   +1 more source

Extended interval dosing of natalizumab in multiple sclerosis

Journal of Neurology Neurosurgery & Psychiatry, 2016
L. Z. Ryerson, T. Frohman, J. Foley, I. Kister, B. Weinstock-Guttman, C. Tornatore, K. Pandey, S. Donnelly, S. Pawate, R. Bomprezzi, David C. Smith, C. Kolb, S. Qureshi, D. Okuda, J. Kalina, Z. Rimler, R. Green, N. Monson, T. Hoyt, M. Bradshaw, J. Fallon, E. Chamot, M. Bucello, Shin C. Beh, Gary Cutter, E. Major, J. Herbert, E. Frohman   +27 more
semanticscholar   +1 more source

A proposed dosing algorithm for the individualized dosing of human immunoglobulin in chronic inflammatory neuropathies

Journal of the peripheral nervous system, 2016
M. Lunn, Lauren Ellis, R. Hadden, Y. Rajabally, J. Winer, M. Reilly   +5 more
semanticscholar   +1 more source

Pharmacokinetic Dashboard-Recommended Dosing Is Different than Standard of Care Dosing in Infliximab-Treated Pediatric IBD Patients

AAPS Journal, 2016
M. Dubinsky, Becky L. Phan, Namita Singh, S. Rabizadeh, D. Mould   +4 more
semanticscholar   +1 more source